Tow excepts From CNBC
“Notably, Pfizer expects a 40-cent per share hit from financing costs related to its $43 billion acquisition of cancer drug developer
Seagen, which it plans to formally close Thursday.
After raking in billions of dollars from its Covid products, Pfizer has struggled to navigate a world beyond the pandemic and reassure investors about its growth potential. Pfizer is hoping to shift investor focus toward its record drug pipeline, which includes a handful of cancer drugs from Seagen. “
My take: I get that companies use debt leverage when it’s favorable but where’s the cash from Covid sales? We take a $0.40 hit for financing the $43B acquisition that doesn’t return $10B until the end of the decade? We must have a ton of retained cash.
CNBC writers see that PFE had no plan before Covid and gained no focus or plan when showered with billions in unforecasted sales. Please get activist investors to buy in at this decade low and force change.
Lastly, why do we sound like we lament low Covid rates or that people feel the pandemic is over? Either publicly celebrate our role in helping hurdle the worst of the pandemic or look in the mirror to recognize why the public doesn’t understand or trust what we sell. Leadership matters and we are in deficit